CVC acquires DSM ANIMAL NUTRITION AND HEALTH BUSINESS (2026)

Deal facts

Buyer: CVC
Target: DSM ANIMAL NUTRITION AND HEALTH BUSINESS
Deal value: Not disclosed
Announced: 18 May 2026
Status: Firm intention
Sector: Food & Drink
Country: Not stated
Consideration: Not stated

Sources

What we know

CVC has agreed to acquire the DSM Animal Nutrition and Health Business in a strategic acquisition within the Food and Drink sector. The transaction was announced on 18 May 2026. The specific financial terms of the deal have not been disclosed to the public. No details regarding the consideration structure or the specific countries involved in the transaction have been reported in the available data.

The deal is currently at the firm intention stage. Both parties have confirmed their commitment to proceed with the acquisition, subject to the completion of standard due diligence processes. The transaction remains pending regulatory approval and other customary closing conditions before it can be finalised. Further updates regarding the completion date will be released once the necessary approvals are secured.

More M&A Tools

Explore the Toolkit

Tools, frameworks and AI assistants designed for entrepreneurs serious about M&A.

Access now

Deal timeline

1 update

18 May 2026Firm intention
CVC / DSM ANIMAL NUTRITION AND HEALTH BUSINESS
FormalInvestigationPhase1Merger CVC / DSM ANIMAL NUTRITION AND HEALTH BUSINESS
EU DG COMP

OpinionExit Mode editorial

We see a clear signal in the CVC agreement to acquire the DSM Animal Nutrition and Health Business. This transaction, announced on 18 May 2026, marks a firm intention rather than a binding completion, yet it shifts the landscape for the Food and Drink sector. The move separates a specialist nutrition arm from a broader scientific group, suggesting that focused operational platforms now attract more interest than diversified conglomerates. For the SME founder reading this, the lesson is that niche expertise within a larger corporate structure can become a standalone asset worth pursuing by private equity, provided the business model is distinct and scalable.

The deal type is classified as a strategic acquisition, yet the buyer is a private equity firm. This hybrid approach often triggers specific regulatory scrutiny in the UK and EU. We must note that any change of control for a business with significant market share in animal health will likely face a CMA review. The acquirer must navigate competition thresholds and ensure that the separation of the target from DSM does not disrupt supply chains or harm market competition. Furthermore, the firm intention status implies that due diligence is still underway. This phase often reveals hidden liabilities or regulatory hurdles that can delay completion or force a restructuring of the deal terms.

We think the absence of a disclosed value or currency figure is typical for early-stage announcements but creates uncertainty for stakeholders. The reliance on a firm intention status means the deal remains conditional on regulatory clearance and final financing. This is not merely a paperwork exercise; it is a test of the target's resilience under the microscope of antitrust regulators. The buyer must demonstrate that the acquisition will not reduce competition in the animal nutrition market. Failure to secure these clearances could see the transaction collapse, leaving the target in a vulnerable position.

You should audit your own change-of-control covenants this week. Review every major contract with suppliers and customers to identify clauses that might trigger automatic termination or renegotiation upon a sale. Many founders overlook these provisions until the deal is announced, only to find their key revenue streams are at risk. Fixing these issues now, while you still have control, is the only way to ensure your business remains attractive to buyers like CVC when the time comes.

Editorial opinion. Not financial or legal advice.

Explore

Browse adjacent archives

Jump from this deal into the sector, buyer, deal type, and year views that carry the strongest contextual signal.

More Food & Drink deals More 2026 deals More strategic acquisition deals More from CVC All M&A deals

Similar deals

Other Food & Drink M&A activity tracked by Exit Mode.

30 September 2026Firm intentionFood & Drink

Hormel Foods Corporation to acquire Brakebush Brothers, LLC

Hormel Foods Corporation has agreed to acquire Brakebush Brothers, LLC in a strategic acquisition. The transaction, announced on 30 September 2026, is valued at 1.055 bi…

Buyer: Hormel Foods Corporation
Target: Brakebush Brothers, LLC
Deal value: USD 1,055,000,000
Deal type: strategic acquisition

Read deal Food & Drink deals strategic acquisition deals United States deals

24 September 2026In reviewFood & Drink

VITAMIN WELL GROUP to acquire EMPWR NUTRITION GROUP

VITAMIN WELL GROUP has agreed to acquire EMPWR NUTRITION GROUP in a strategic acquisition within the Food and Drink sector. The transaction was announced on 24 September…

Buyer: VITAMIN WELL GROUP
Target: EMPWR NUTRITION GROUP
Deal value: Not disclosed
Deal type: strategic acquisition

Read deal Food & Drink deals strategic acquisition deals In review deals

10 August 2026CompletedFood & Drink

Nichols plc to acquire VITHIT Limited

Nichols plc has agreed to acquire VITHIT Limited, a food and drink business based in Ireland, in a strategic acquisition valued at EUR 75 million. The transaction, which…

Buyer: Nichols plc
Target: VITHIT Limited
Deal value: EUR 75,000,000
Deal type: strategic acquisition

Read deal Food & Drink deals strategic acquisition deals Ireland deals

7 August 2026CompletedFood & Drink

Yum China Holdings, Inc. to acquire Yum! Brands, Inc.

Yum China Holdings, Inc. has agreed to acquire Yum! Brands, Inc. in a strategic acquisition within the Food and Drink sector. The transaction, announced and completed on…

Buyer: Yum China Holdings, Inc.
Target: Yum! Brands, Inc.
Deal value: USD 1,200,000,000
Deal type: strategic acquisition

Read deal Food & Drink deals strategic acquisition deals United States deals

31 July 2026Firm intentionFood & Drink

Livekindly Production NL B.V. to acquire Dalco Food B.V.

Livekindly Production NL B.V. has agreed to acquire Dalco Food B.V. in a strategic acquisition valued at 5.4 million GBP. The transaction involves a cash consideration a…

Buyer: Livekindly Production NL B.V.
Target: Dalco Food B.V.
Deal value: GBP 5,400,000
Deal type: strategic acquisition

Read deal Food & Drink deals strategic acquisition deals Netherlands deals

Buyer history

CVC

See every published Exit Mode archive entry where this buyer appears.

View buyer profile

Methodology

How this page is built

Layer 1 facts come from source documents, Layer 2 turns those facts into a readable narrative, and Layer 3 only appears where the editorial team flags a founder-relevant deal.

Back to the archive

CVC to acquire DSM ANIMAL NUTRITION AND HEALTH BUSINESS